weight loss, GLP-1

'Probably going to be the most prescribed drug'; The future of weight loss drugs
Drugs like Ozempic, Wegovy and Mounjaro are changing the game for weight loss.  GLP-1 medications were originally intended to treat type 2 diabetes, but a growing number of people are using it for weight loss.
GLP-1 Drugs For Weight Loss Aren’t Cost-Saving Yet
Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug spending. But thus far, the data don’t show this.
The Latest Science About GLP-1 Drugs & Weight Loss
Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?
I’m a weight-loss doctor — the unusual complication I’m seeing from Ozempic-like drugs
A top NYC weight-loss doctor shared the surprising skin complication that he’s encountered in patients using GLP-1 drugs like Ozempic.
How weight-loss drugs will impact restaurants
The podcast features Numerator Chief Economist Leo Feler, who talks about the potential impact of GLP-1 drugs like Ozempic
Can Microdosing Weight Loss Drugs Like Ozempic Help You Lose Weight?
Proponents of Ozempic microdosing claim you'll reap the drug's benefits with fewer side effects. But is taking small doses of GLP-1 agonists safe and effective for weight loss?
Was Ozempic The Secret To Kelly Clarkson's Weight Loss Transformation? What She's Said
Kelly Clarkson has had an incredible weight loss transformation and she has finally revealed whether or not the medication Ozempic was the reason.
Employee Benefit News10h
A guide to GLP-1 adoption: How employers can add this benefit in 2025
While weight loss is a common new year's resolution for workers in the U.S., 2025 may mark the year that building weight loss ...
Medscape8d
Early Intervention Central to Treating Muscle Mass Loss in Patients Losing Weight With GLP-1 Meds
Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...
24/7 Wall St. on MSN13h
Down 23%, Is This Dividend Giant a Buy After GLP-1 Sales Miss?
Next to artificial intelligence, weight-loss drugs have been one of the biggest themes investors latched onto in 2024. Eli ...
Civic Science on MSN5h
GLP-1 Trends by CivicScience: Current Users Report Shifts in Retail Shopping and Alcohol Consumption, Plus More Insights
This is just a glimpse of the GLP-1 trends available to CivicScience clients. Want to see the full picture? Let’s talk.
Maker of weight-loss drugs to ask Trump to pause price negotiations: Report
Eli Lilly and other drugmakers are reportedly planning to urge the Trump administration to pause Medicare drug-price ...
Healio10h
Top in endocrinology: Novel GLP-1 lowers weight; osteoporosis detection with CT plus AI
Patients with overweight or obesity who used maridebart cafraglutide experienced significant weight loss at 1 year, according ...
As Lilly Stock Tumble on GLP-1 Demand Worries, CEO Says All Is Well
Sales results disclosed Tuesday raised concern that investors may have overestimated the demand for Zepbound and Mounjaro.
Oral Ozempic and a ‘miracle’ pill imitating the keto diet – a new era of weight loss is here
The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...